Share on LinkedInShare on LinkedIn

ARTICLE · 24 JANUARY 2024

How Bayer And Takeda Pharmaceuticals Use IP E-Learning To Prevent Common IP Risks And Missed IP Opportunities

In today's fast-paced business world, the demand for expedited product and service launches that outperform the competition in terms of quality, speed, and affordability is higher than ever.

GlobalIntellectual Property

Preventing Common IP Risks with eLearning

In today's fast-paced business world, the demand for expedited product and service launches that outperform the competition in terms of quality, speed, and affordability is higher than ever. This presents a myriad of distinct IP challenges for businesses.

Rewatch our webinar to explore innovative approaches in utilizing eLearning to address the complexities associated with your IP strategy. Gain valuable insights from Executive IP's Raymond Guarnieri, joined by industry experts Henning Luetjens, Head of Patents at Bayer Intellectual Property GmbH, and Mario Cloutier, Senior Patent Agent at Takeda Pharmaceuticals. You will discover how they effectively employ Executive IP to confront and overcome IP challenges in their respective domains.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from